CD262, Human (Conatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD262, Human (Conatumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD262, Human (Conatumumab biosimilar)
CloneConatumumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD262 Recombinant Antibody (Conatumumab). Conatumumab (originally AMG-655) is a monoclonal antibody developed for the treatment of cancer. It is a fully human monoclonal agonist antibody directed against the extracellular domain of human TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptor 2 (TR-2, death receptor 5) with potential antineoplastic activity.
Immunogenn/a
Other NamesAnti-CD262 Recombinant Antibody, Research Grade Conatumumab, Anti-Human CD262 Recombinant Antibody(Conatumumab), AMG 655, TRAIL-R2mAb, XG1-048vw, Antibody Drug Analogues, Monoclonal Antibody, YR1142, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 896731-82-1
Catalog #YR1142
Priceplease inquire
Order / More InfoCD262, Human (Conatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.